| 000 | 01400 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512080050.0 | ||
| 264 | 0 | _c19851220 | |
| 008 | 198512s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.44.11.754 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohrland, J S | |
| 245 | 0 | 0 |
_aA multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cNov 1985 |
||
| 300 |
_a754-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlprostadil _xadverse effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRaynaud Disease _xdrug therapy |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSkin Temperature _xdrug effects |
| 700 | 1 | _aPorter, J M | |
| 700 | 1 | _aSmith, E A | |
| 700 | 1 | _aBelch, J | |
| 700 | 1 | _aSimms, M H | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 44 _gno. 11 _gp. 754-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.44.11.754 _zAvailable from publisher's website |
| 999 |
_c3910330 _d3910330 |
||